ASCRS Ch69 - Ethical Considerations (Conflict of Interest, Surgical Innovation, and End of Life)

Chapter 69 of the ASCRS Textbook of Colon and Rectal Surgery, 4th edition (Buie WD, MacLean AR), book pages 1127-1138 (PDF pages 1110-1121, offset +17). Part of the "Part VI: Miscellaneous" grouping, immediately following ASCRS Ch68 - Healthcare Economics — the second consecutive non-clinical chapter in this sequential ingest.

Structure

• Conflict of Interest in Surgical Research — classification (financial vs. nonfinancial/intellectual/ professional), determining COI (Fineberg's reasonable-person standard), reporting COI and effect on study outcomes (industry-sponsorship bias evidence, the Vioxx case study, Cherla et al.'s surgeon-vs-OPD discordance finding, systematic review COI underreporting), management strategies (disclosure, elimination, balance, exclusion), and COI in the peer review process.
• Introduction of Surgical Innovation — incorporating new techniques/technologies (the laparoscopic cholecystectomy and taTME cautionary case studies), oversight frameworks (Society of University Surgeons position statement, the IDEAL Collaboration's five-stage framework), informed consent for innovative procedures, outcomes-tracking obligations, and industry's dual role (enabling adoption vs. creating COI).
• End-of-Life and Surgical Care — Communication (the SUPPORT trial, "clinical momentum," cultural/ language barriers), Prognostication (time-limited trials, advance directives, surrogate decision-maker calibration), Decision-Making (the four principles — autonomy/beneficence/ non-maleficence/justice — shared decision-making, the best case/worst case framework, double effect, withdrawal-of-care criteria, cultural variation in decision-making authority), and elderly-specific end-of-life surgical considerations.
• Conclusions (per section) and References (87 citations).

Wiki disposition

Written to a new standalone concept page, Surgical Ethics (Conflict of Interest, Innovation & End-of-Life Care) — no existing wiki page covered any of these three ethics domains. Light cross-reference added to Total Mesorectal Excision (TME) & Sphincter-Sparing Resection given the chapter's explicit use of taTME as a surgical-innovation cautionary case study (the urethral-injury registry signal and Norway/ Netherlands moratorium/recurrence reports, already covered clinically on that page).

Offset verification

Chapter opens on book page 1127 (PDF page 1110), copyright line confirms "© Springer Nature Switzerland AG 2022 1127" — offset +17, unchanged from Ch. 68 (Ch. 68 ended on an even book page, 1126, so no jump was expected or found). Chapter ends on book page 1138 (even page); no jump occurs at the Ch. 69/Ch. 70 boundary — Ch. 70 ("Welcome to Litigation," Ames DK) confirmed starting at book page 1139 (PDF page 1122), offset +17 unchanged (copyright line confirms "© Springer Nature Switzerland AG 2022 1139").